Home/Filings/4/0000899243-21-036773
4//SEC Filing

Fox Allan M. 4

Accession 0000899243-21-036773

CIK 0001590877other

Filed

Sep 20, 8:00 PM ET

Accepted

Sep 21, 4:15 PM ET

Size

8.6 KB

Accession

0000899243-21-036773

Insider Transaction Report

Form 4
Period: 2021-09-17
Fox Allan M.
Director
Transactions
  • Sale

    Common Stock

    2021-09-17$45.04/sh48,233$2,172,3231,364,309 total(indirect: By LLC)
Holdings
  • Common Stock

    (indirect: By Trust)
    278,541
  • Common Stock

    (indirect: By Trust)
    315,000
  • Common Stock

    (indirect: By Trust)
    315,000
  • Common Stock

    (indirect: By Trust)
    722,485
Footnotes (2)
  • [F1]This transaction was executed in multiple trades at prices ranging from $45.00 to $45.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]The reporting person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Issuer

REGENXBIO Inc.

CIK 0001590877

Entity typeother

Related Parties

1
  • filerCIK 0001652936

Filing Metadata

Form type
4
Filed
Sep 20, 8:00 PM ET
Accepted
Sep 21, 4:15 PM ET
Size
8.6 KB